Company Performance Metrics
Zetiq has developed a unique proprietary platform, the CellDetect. It is registered technology, for the detection of cancer cells via discriminate staining of cancer cells among normal cells, while preserving the morphological features of the cells. The unique platform technology enables color discrimination between red cancer cells and green
non-cancer cells. Using a simple in-vitro procedure to stain cells they offer dual-color and morphological diagnostic products that are resource-saving and amendable to automation, in a wide range of cancer indications. Products originating from the platform CellDetect:registered: Technology has achieved positive results in targeted clinical trials, and Zetiq intends to expand the development of products of the CellDetect towards the high market value of cancer diagnosis.
